AIMARETTI, Gianluca
 Distribuzione geografica
Continente #
EU - Europa 6.366
NA - Nord America 5.246
AS - Asia 1.539
SA - Sud America 30
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 11
OC - Oceania 10
Totale 13.225
Nazione #
US - Stati Uniti d'America 5.194
IE - Irlanda 2.167
DE - Germania 1.006
SE - Svezia 882
IT - Italia 781
UA - Ucraina 777
CN - Cina 514
FI - Finlandia 466
SG - Singapore 363
HK - Hong Kong 275
IN - India 174
FR - Francia 82
VN - Vietnam 77
GB - Regno Unito 71
IR - Iran 54
CA - Canada 50
NL - Olanda 39
CZ - Repubblica Ceca 29
BE - Belgio 26
EU - Europa 23
TR - Turchia 22
BR - Brasile 13
AU - Australia 10
PK - Pakistan 10
JP - Giappone 9
KR - Corea 9
PE - Perù 9
MY - Malesia 7
IL - Israele 6
ES - Italia 5
PH - Filippine 5
RU - Federazione Russa 5
CH - Svizzera 4
GR - Grecia 4
LT - Lituania 4
MO - Macao, regione amministrativa speciale della Cina 4
RO - Romania 4
ZA - Sudafrica 4
AR - Argentina 3
CL - Cile 3
PL - Polonia 3
TH - Thailandia 3
BD - Bangladesh 2
EG - Egitto 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
Totale 13.225
Città #
Dublin 2.160
Jacksonville 1.476
Dearborn 696
Wilmington 432
Chandler 289
Lawrence 275
Princeton 275
Hong Kong 263
Singapore 246
San Mateo 215
Beijing 214
Andover 157
Ann Arbor 152
Ashburn 125
Piemonte 105
Bremen 99
Dong Ket 74
Milan 60
Turin 54
Helsinki 53
Hefei 46
Munich 44
Boardman 40
Norwalk 40
Novara 39
Houston 38
Düsseldorf 37
Philadelphia 36
Kunming 35
Nanjing 30
Fairfield 29
Brno 27
Brussels 24
Woodbridge 24
Torino 23
Paris 22
Toronto 22
Zanjan 22
Nanchang 21
Cassano Magnago 19
Monmouth Junction 19
Santa Clara 19
Leawood 17
Rome 16
Alessandria 15
Jinan 15
Dronten 14
Bologna 13
Kocaeli 13
Vercelli 13
Guangzhou 12
Zhengzhou 12
Ardabil 11
Chennai 10
Montreal 10
West Jordan 10
Augusta 9
Fuzhou 9
Shenyang 9
Frankfurt am Main 8
Grafing 8
Seattle 8
Sydney 8
São Paulo 8
Borgo Vercelli 7
London 7
Sham Shui Po 7
Berlin 6
Dallas 6
Espoo 6
Hebei 6
Naples 6
Shaoxing 6
Tehran 6
Wuhan 6
Baotou 5
Chimbote 5
Napoli 5
Nardò 5
Ottawa 5
Palermo 5
Shanghai 5
Strasbourg 5
Xian 5
Cambridge 4
Changsha 4
Johannesburg 4
Lima 4
Macao 4
New York 4
Pescantina 4
Portland 4
Redwood City 4
San Diego 4
Senigallia 4
Trivero 4
Winnipeg 4
Agrate Conturbia 3
Amsterdam 3
Athens 3
Totale 8.499
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 241
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 145
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 104
Change over time of COVID-19 hospital presentation in Northern Italy 96
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 95
Molecular analysis of the Growth Hormone Releasing Hormone Receptor (GHRH-R) gene in Isolated Growth Hormone Deficiency (IGHD): identification of a likely etiological mutation in the signal peptide. 92
Autophagy and thyroid carcinogenesis: genetic and epigenetic links 91
Evaluation of the short-term effects of dietary supplement “Flebotrofine” on markers of endothelial dysfunction in type 2 diabetes patients: a pilot study. 91
Identification of Haptoglobin as a Readout of rhGH Therapy in GH Deficiency 88
Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy 87
Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man. 86
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 79
Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency. 78
Influence of UV radiation on the association between 25-hydroxy vitamin D levels and cardiovascular risk factors in obesity. 78
Effects of phenylalanine, histidine, and leucine on basal and GHRH-stimulated GH secretion and on PRL, insulin, and glucose levels in short children. Comparison with the effects of arginine. 76
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 76
Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin 75
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 75
Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life 74
Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS) 72
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 71
Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. 70
Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. 69
Transsphenoidal surgery for pituitary adenomas: early results from a single center 69
Targeting microbiota in dietary obesity management: a systematic review on randomized control trials in adults 68
MOLECULAR ANALYSIS OF THE GROWTH HORMONE GENE IN ISOLATED GROWTH HORMONE DEFICIENCY: POSSIBILE INVOLVEMENT OF A PROMOTER POLYMORPHISM 68
How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings? 68
Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy 68
Thyroid cancer phenotypes in relation to inflammation and autoimmunity 66
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. 65
Appropriate use of stimulation tests and insulin-like growth factor-I in obesity 65
Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. 64
Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism 64
GHRH an GH secretagogues: clinical perspectives and safety. 64
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 64
PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. 64
Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: Association with insulin sensitivity and metabolic alterations. 64
Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood. 64
One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study. 62
Effects of Growth Hormone (GH) Therapy Withdrawal on Glucose Metabolism in Not Confirmed GH Deficient Adolescents at Final Height. 62
Acylated and unacylated ghrelin levels in normal weight and obese children: influence of puberty and relationship with insulin, leptin and adiponectin levels. 62
Ovotesticular Disorder of Sex Development: A Rare Case of Lateral Subtype 45X/46XY kariotype Diagnosed in Adulthood 62
THE RELATIONSHIP BETWEEN CORTISOL AND IGF-I INFLUENCES METABOLIC ALTERATION IN PEDIATRIC OVERWEIGHT AND OBESITY 62
New approach to the diagnosis of growth hormone deficiency in adults. 61
Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. 61
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 61
Ghrelin gene polymorphisms and ghrelin, insulin, IGF-I, leptin and anthropometric data in children and adolescents 61
Adrenal sensitivity to ACTH1-24 as function of age, body weight and pituitary function. 61
IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency. 60
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism. 60
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 60
Embolization for Insulinoma in Complicated Severe Obesity: Description of an Inoperable Case and Review of the Literature 60
Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome 60
DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement. 59
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 59
Clinical picture and the treatment of TBI-induced hypopituitarism 59
GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. 58
Unusual metastases from tall cell variant of papillary thyroid cancer 58
Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity 57
Activity of GH/IGF-1 axis in burn patients: comparison with normal subjects and patients with GH deficiency. 57
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 57
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 57
IGF-I levels in prepubertal and pubertal children with Down syndrome. 56
Serum leptin levels are not influenced by arginine and insulin infusion and by acute changes of GH. 56
GHRELIN CONCENTRATIONS IN NORMAL AND OBESE CHILDREN: ROLE OF PUBERTY. 56
High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study. 56
Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA. 56
Circulating adipokines and metabolic setting in differentiated thyroid cancer 56
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty. 55
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. 55
The impact of the metabolic phenotype on thyroid function in obesity 55
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 55
Plasma Oxytocin Concentration in Pre- and Postmenopausal Women: Its Relationship with Obesity, Body Composition and Metabolic Variables 55
The lullaby of the sun: the role of vitamin D in sleep disturbance 55
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 55
Aging and comorbidities influence the risk of hospitalization and mortality in diabetic patients experiencing severe hypoglycemia 55
A novel compound heterozygous mutation of the aromatase gene in an adult man: new insight into the role of estrogen on gonadal development. 54
Low dose orally administered arginine is able to enhance both basLow dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. 54
Measurement of Height Velocity is an useful marker for monitoring pituitary function in patients who had traumatic brain injury. 54
Vitamin D as a Biomarker of Ill Health among the Over-50s: A Systematic Review of Cohort Studies. 54
Effectiveness of E-learning training on drug – dosage calculation skills of nursing students: A randomized controlled trial 54
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 54
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. 53
Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. 53
The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency 52
Non-surgical ablative therapies for inoperable benign insulinoma 52
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome 52
GH secretion in Prader-Labhard-Willi syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine. 51
Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency. 51
Metabolic alterations in patients who develop Traumatic Brain Injury (TBI)-induced hypopituitarism. 51
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 51
Vitamin D and neurological diseases: An endocrine view 51
Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach 51
Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span. 50
Preface 50
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. 50
Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals 50
Lymphocytes and immunoglobulin patterns across the threshold of severe obesity 49
Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. 49
Levothyroxine Replacement in Obese Adults: The Role of Metabolic Variables and Aging on Thyroid Testing Abnormalities 49
Totale 6.545
Categoria #
all - tutte 83.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.966 0 0 0 0 0 430 628 117 297 227 264 3
2020/20211.883 254 2 260 6 256 76 280 10 279 49 297 114
2021/20221.909 69 39 305 196 114 25 184 40 137 38 358 404
2022/20233.777 311 176 188 74 226 259 104 128 2.063 31 129 88
2023/20241.332 97 96 75 29 250 43 285 71 23 44 93 226
2024/2025514 62 38 160 90 96 68 0 0 0 0 0 0
Totale 13.544